NCT00429949View on ClinicalTrials.gov

A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Relapsed, Refractory or Plateau Phase Multiple Myeloma
Interventions
DRUG

Dasatinib

Trial Locations (1)

63110

Washington Universtiy in St. Louis, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00429949 - A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma | Biotech Hunter | Biotech Hunter